A. Gatta

发表

Vegetarian diets in hepatic encephalopathy: facts or fantasies?

L. Caregaro, P. Amodio, E. Pattenò, 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Spectral versus visual EEG analysis in mild hepatic encephalopathy

J. Guérit, P. Amodio, A. Gatta, 1999, Clinical Neurophysiology.

The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites

W. Jiménez, V. Arroyo, G. Fernández-Varo, 2005, Liver international : official journal of the International Association for the Study of the Liver.

Renal vasoconstriction in cirrhosis evaluated by duplex doppler ultrasonography

P. Angeli, A. Gatta, D. Sacerdoti, 1993, Hepatology.

SERPINB3, apoptosis and autoimmunity.

P. Pontisso, S. Quarta, A. Doria, 2009, Autoimmunity reviews.

Improvement of Liver Cancer Detection with Simultaneous Assessment of Circulating Levels of Free Alpha-Fetoprotein (AFP) and Afp-Igm Complexes

P. Pontisso, G. Fassina, A. Gatta, 2004, The International journal of biological markers.

Top-down and bottom-up processes in the extrastriate cortex of cirrhotic patients: An ERP study

Antonino Vallesi, Sami Schiff, Daniela Mapelli, 2006, Clinical Neurophysiology.

Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferon.

A. Alberti, P. Pontisso, A. Gatta, 2000, Gastroenterology.

Long term effect of alpha interferon in children with chronic hepatitis B

A. Gatta, G. Gregorio, L. Zancan, 2000, Gut.

Nutritional and prognostic significance of serum hypothyroxinemia in hospitalized patients with liver cirrhosis.

P. Angeli, M. Plebani, L. Caregaro, 1998, Journal of hepatology.

Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow.

A. Avogaro, A. Tiengo, A. Gatta, 1984, The Journal of clinical endocrinology and metabolism.

Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats

P. Pontisso, P. Angeli, A. Gatta, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Early markers of neural dysfunction and compensation: A model from minimal hepatic encephalopathy

P. Bisiacchi, P. Angeli, G. Cona, 2014, Clinical Neurophysiology.

MicroRNAs and SerpinB3 in hepatocellular carcinoma.

P. Pontisso, S. Quarta, A. Gatta, 2014, Life sciences.

Hepatic osteodystrophy.

S. Giannini, A. Gatta, M. Bolognesi, 2014, Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases.

Progressive increase of SCCA‐IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma

P. Pontisso, G. Fassina, S. Quarta, 2006, International journal of cancer.

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

P. Pontisso, C. Belluco, D. Nitti, 2004, British Journal of Cancer.

Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics.

P. Angeli, P. Amodio, A. Gatta, 1995, Gastroenterology.

SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection

P. Pontisso, S. Quarta, L. Iaccarino, 2012, Experimental biology and medicine.

Effects of chronic therapy with nadolol on portal hemodynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1997, Journal of hepatology.

Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis.

P. Angeli, L. Caregaro, P. Amodio, 1994, Archives of internal medicine.

Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: a new exception to MELD score in the allocation system to liver transplantation?

P. Angeli, A. Gatta, S. Fasolato, 2011, Journal of hepatology.

Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices.

A. Gatta, D. Gregori, A. Buja, 2014, World journal of gastroenterology.

Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance

P. Angeli, L. Caregaro, A. Gatta, 1990, European journal of clinical investigation.

Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen)

J. Benichou, M. Sturkenboom, J. Montastruc, 2013, Drug Safety.

The hunter and the pianist: two hepatic encephalopathy tales.

G. Cona, P. Amodio, A. Gatta, 2011, Journal of clinical gastroenterology.

Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites: a real‐life cross‐sectional study

P. Angeli, L. Caregaro, A. Gatta, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Biological and clinical implications of HBV infection in peripheral blood mononuclear cells.

P. Pontisso, S. Quarta, A. Gatta, 2008, Autoimmunity reviews.

SERPINB3 is associated with longer survival in transgenic mice

A. Avogaro, P. Pontisso, G. Ceolotto, 2013, Scientific Reports.

Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection

A. Alberti, A. Gatta, F. Noventa, 2002, Annals of Internal Medicine.

Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry

A. Farcomeni, F. Perticone, S. Basili, 2016, Internal and Emergency Medicine.

A patients’ and caregivers’ perspective on hepatic encephalopathy

S. Schiff, P. Angeli, P. Amodio, 2012, Metabolic Brain Disease.

Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: Analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters

M. Rugge, L. Giacomelli, A. Gatta, 2007, Scandinavian journal of gastroenterology.

Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.

L. Bolondi, F. Piscaglia, F. Trevisani, 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Evaluation of the efficacy and safety of flumazenil

A. Gatta, Roger M. Williams, R. Amrein, 2006 .

Olfactory deficits in patients affected by minimal hepatic encephalopathy: a pilot study.

G. Zucco, P. Amodio, A. Gatta, 2006, Chemical senses.

Electroencephalographic staging of hepatic encephalopathy by an artificial neural network and an expert system 1

S. Schiff, P. Amodio, A. Gatta, 2005, Neurophysiologie Clinique/Clinical Neurophysiology.

A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis.

P. Angeli, A. Gatta, M. Bolognesi, 2004, Gastroenterology.

Alterations in thyroid Doppler arterial resistance indices, volume and hormones in cirrhosis: relationships with splanchnic haemodynamics.

A. Gatta, L. Spadaro, D. Sacerdoti, 2004, Ultrasound in Medicine and Biology.

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development

A. Alberti, P. Pontisso, A. Gatta, 2001, Gut.

Splenic impedance indices: A useful method to monitor patients after liver transplantation?

P. Angeli, A. Gatta, G. Gerunda, 1998, Hepatology.

Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE.

P. Angeli, J. Mcgiff, A. Gatta, 1997, The Journal of clinical investigation.

Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis

P. Amodio, A. Gatta, C. Mazzaro, 1996, The Lancet.

Relationship between portal blood flow measured by image‐directed doppler ultrasonography and hepatic blood flow measured by indocyanine green constant infusion in patients with cirrhosis

A. Gatta, D. Sacerdoti, M. Bolognesi, 1995, Journal of clinical ultrasound : JCU.

Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis

P. Angeli, P. Amodio, A. Gatta, 1994, Hepatology.

Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide‐5‐mononitrate in cirrhotic patients.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1994, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.

A. Gatta, M. Bolognesi, M. Di Pascoli, 2014, World journal of gastroenterology.

Thrombosis of the portal venous system.

S. Gaiani, A. Gatta, D. Sacerdoti, 2007, Journal of ultrasound.

Comparison between two high‐dose methylprednisolone schedules in the treatment of acute hepatic cellular rejection in liver transplant recipients: A controlled clinical trial

M. Strazzabosco, P. Angeli, F. Del Piccolo, 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Splenic Doppler impedance indices estimate splenic congestion in patients with right-sided or congestive heart failure.

S. Gaiani, A. Gatta, P. Pesce, 2012, Ultrasound in medicine & biology.

Acute effects of the oral administration of midodrine, an α‐adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites

E. Casiglia, P. Angeli, A. Gatta, 1998, Hepatology.

Role of Atrial Natriuretic Peptide in the Pathogenesis of Sodium Retention in IDDM With and Without Glomerular Hyperfiltration

A. Gatta, F. Mantero, P. Fioretto, 1992, Diabetes.

Lack of correlation between endotoxaemia and renal hypoperfusion in cirrhotics without overt renal failure

L. Caregaro, P. Amodio, A. Gatta, 1982, European journal of clinical investigation.

Intrarenal blood flow, circulation time, and cortical vascular volume in patients with cirrhosis.

P. Amodio, A. Gatta, C. Merkel, 1981, Scandinavian journal of gastroenterology.

ENDOTOXINS AND THE HEPATORENAL SYNDROME

L. Caregaro, P. Amodio, A. Gatta, 1981, The Lancet.

Squamous cell carcinoma antigen‐immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma

P. Pontisso, G. Fassina, S. Quarta, 2005, Cancer.

Neurological complications after orthotopic liver transplantation.

P. Angeli, P. Amodio, A. Gatta, 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cirrhosis and muscle cramps: Evidence of a causal relationship

P. Angeli, M. Plebani, L. Caregaro, 1996, Hepatology.

Renal water and sodium handling in compensated liver cirrhosis: mechanism of the impaired natriuresis after saline loading

P. Angeli, L. Caregaro, A. Gatta, 1985, European journal of clinical investigation.

Effects of captopril on renal function in hypertensive patients.

E. Casiglia, P. Palatini, A. Semplicini, 1982, The American journal of cardiology.

Hypotensive and renal effects of Captopril

E. Casiglia, A. Semplicini, P. Amodio, 1981, European journal of clinical investigation.

Renal cytochrome P-450-dependent metabolism of arachidonic acid in cirrhotic rats.

N. Abraham, M. Schwartzman, J. Mcgiff, 1991, Journal of hepatology.

Increased EETs participate in peripheral endothelial dysfunction of cirrhosis.

S. Gaiani, A. Gatta, P. Pesce, 2012, Prostaglandins & other lipid mediators.

Clinical pharmacology of splanchnic circulation in cirrhosis.

A. Gatta, C. Merkel, 1990, Pharmacological research.

Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.

A. Gatta, M. Bolognesi, C. Merkel, 2008, Molecular aspects of medicine.

Peripheral neurotoxicity of pegylated interferon alpha

M. Ermani, L. Battistin, C. Briani, 2006, Neurology.

Haeme oxygenase mediates hyporeactivity to phenylephrine in the mesenteric vessels of cirrhotic rats with ascites

P. Pontisso, P. Angeli, S. Quarta, 2005, Gut.

Mesenteric arteries responsiveness to acute variations of wall shear stress is impaired in rats with liver cirrhosis

A. Gatta, F. Zampieri, D. Sacerdoti, 2012, Scandinavian journal of gastroenterology.

CLINICAL TRIALS STUDY

Bolognesi, P. Angeli, P. Amodio, 2014 .

Prognostic indicators of survival in patients with cirrhosis and esophageal varices, without previous bleeding.

P. Angeli, L. Caregaro, A. Gatta, 1989, The American journal of gastroenterology.

An abnormal gene expression of the β‐adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats

P. Angeli, G. Ceolotto, A. Semplicini, 2008, Hepatology.

Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders.

L. Caregaro, A. Gatta, P. Santonastaso, 2001, Clinical nutrition.

Pathophysiology of Portal Hypertension

A. Gatta, M. Bolognesi, 2000 .

Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms

P. Angeli, G. Ceolotto, A. Gatta, 2013, Hepatology.

Carbon Monoxide-Mediated Activation of Large-Conductance Calcium-Activated Potassium Channels Contributes to Mesenteric Vasodilatation in Cirrhotic Rats

P. Angeli, S. Quarta, A. Gatta, 2007, Journal of Pharmacology and Experimental Therapeutics.

New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?

A. Frigo, P. Angeli, A. Gatta, 2015, Liver international : official journal of the International Association for the Study of the Liver.

THE HEME OXYGENASE/CARBON MONOXIDE SYSTEM IN HEPATOBILIARY PATHOPHYSIOLOGY

A. Gatta, D. Sacerdoti, 2002 .

CORRIGENDUM: SERPINB3 is associated with longer survival in transgenic mice

A. Avogaro, P. Pontisso, G. Ceolotto, 2014, Scientific Reports.

Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: Pathophysiological and clinical implications

P. Angeli, L. Caregaro, A. Gatta, 1992, Hepatology.

hepatocellular carcinoma . the liver of cirrhotic patients with chemoembolisation on metabolic activity of Short-term effects of transcatheter arterial

A. Gatta, D. Miotto, M. Bolognesi, 2006 .

Short-term effects of transcatheter arterial chemoembolisation on metabolic activity of the liver of cirrhotic patients with hepatocellular carcinoma.

A. Gatta, D. Miotto, M. Bolognesi, 1996, Gut.

Nifedipine versus carvedilol in the treatment of de novo arterial hypertension after liver transplantation: Results of a controlled clinical trial

A. Frigo, P. Angeli, A. Semplicini, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Increased activity of guanosine 3′‐5′‐cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites

W. Jiménez, V. Arroyo, P. Angeli, 2000, Hepatology.

Blood flow of experimental liver metastases in rat as evaluated by the locally injected 133-Xenon washout

A. Gatta, D. Sacerdoti, M. Bolognesi, 1985, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase.

N. Abraham, M. Schwartzman, J. Mcgiff, 2006, American journal of physiology. Heart and circulatory physiology.

Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice.

P. Pontisso, G. Fassina, S. Quarta, 2009, International journal of molecular medicine.

Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure

P. Pontisso, P. Amodio, A. Gatta, 2012, Experimental biology and medicine.

Insulin-like growth factor 1 (IGF-1) in liver cirrhosis: a marker of hepatocellular dysfunction?

P. Angeli, L. Caregaro, A. Gatta, 1998, Journal of hepatology.

Hypophosphatemia and renal tubular dysfunction in alcoholics. Are they related to liver function impairment?

P. Angeli, L. Caregaro, A. Gatta, 1991, Gastroenterology.

COMPARISON BETWEEN NIFEDIPINE AND CARVEDILOL IN THE TREATMENT OF “DE NOVO” ARTERIAL HYPERTENSION AFTER LIVER TRANSPLANTATION (LT): PRELIMINARY RESULTS OF A CONTROLLED CLINICAL TRIAL.

P. Angeli, A. Semplicini, A. Gatta, 2004 .

Renal effects of nadolol in cirrhosis

L. Caregaro, A. Gatta, D. Sacerdoti, 2004, European Journal of Clinical Pharmacology.

Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge

P. Angeli, A. Gatta, S. Piano, 2012, European journal of gastroenterology & hepatology.

Q-T interval prolongation in liver cirrhosis. Reversibility after orthotopic liver transplantation.

P. Angeli, A. Gatta, D. Sacerdoti, 1998, Japanese heart journal.

11,12-epoxyeicosatrienoic acid stimulates heme-oxygenase-1 in endothelial cells.

J. Falck, N. Abraham, M. Schwartzman, 2007, Prostaglandins & other lipid mediators.

Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2.

A. Gatta, D. Sacerdoti, C. Merkel, 1986, Journal of hepatology.

Renal and intrarenal blood flow in patients with cirrhosis before and after portal-systemic shunt.

A. Gatta, C. Merkel, R. Zuin, 1980, Scandinavian journal of gastroenterology.

Effects of iloprost, a prostacyclin analog derivative, on renal plasma flow, renal function, and renin‐aldosterone system in humans

P. Angeli, L. Caregaro, A. Gatta, 1988, Clinical pharmacology and therapy.

Effect of 8-day therapy with propionyl-L-carnitine on muscular and subcutaneous blood flow of the lower limbs in patients with peripheral arterial disease.

P. Amodio, A. Gatta, M. Bolognesi, 1995, Clinical physiology.

11,12-EET increases porto-sinusoidal resistance and may play a role in endothelial dysfunction of portal hypertension.

S. Gaiani, J. Mcgiff, A. Gatta, 2011, Prostaglandins & other lipid mediators.

Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity.

P. Angeli, M. Plebani, P. Amodio, 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report

P. Pontisso, P. Angeli, A. Gatta, 2017, Digestive Diseases.

ANP and PRA system response to phlebotomy.

E. Casiglia, A. Gatta, A. Pessina, 1990, American heart journal.

Neurocognitive-neurological complications of liver transplantation: a review

P. Amodio, A. Gatta, F. Campagna, 2010, Metabolic Brain Disease.

Heme oxygenase regulates renal arterial resistance and sodium excretion in cirrhotic rats.

S. Quarta, A. Gatta, F. Zampieri, 2011, Journal of hepatology.

Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles

P. Pontisso, F. Mancin, S. Quarta, 2016, Bioconjugate chemistry.

Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost

P. Angeli, A. Gatta, C. Antona, 2006, Alimentary pharmacology & therapeutics.

Role of HO/CO in the Control of Peripheral Circulation in Humans

S. Gaiani, A. Gatta, P. Pesce, 2012, International journal of hypertension.

A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped‐care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients

P. Angeli, L. Caregaro, A. Gatta, 1991, Hepatology.

Assessment of alcohol consumption in liver transplant candidates and recipients: The best combination of the tools available

P. Angeli, M. Plebani, A. Gatta, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.

A. Gatta, C. Merkel, R. Nosadini, 1985, Digestion.

Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1987, Journal of hepatology.

The use of human albumin millimicrospheres tagged with 99mTc in the evaluation of the removal capacity of the reticuloendothelial system

A. Gatta, M. Bolognesi, C. Merkel, 2004, European Journal of Nuclear Medicine.

Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics.

P. Angeli, A. Gatta, D. Sacerdoti, 1987, Clinical physiology.

Splenic Doppler impedance indices: Influence of different portal hemodynamic conditions

P. Angeli, A. Gatta, G. Gerunda, 1996, Hepatology.

Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial

P. Angeli, A. Gatta, S. Fasolato, 2009, Gut.

clinical trial cirrhosis : results of an open randomised of ascites in non-azotaemic patients with Combined versus sequential diuretic treatment

P. Angeli, A. Gatta, S. Fasolato, 2009 .

Paraumbilical vein patency in cirrhosis: Effects on hepatic hemodynamics evaluated by doppler sonography

A. Gatta, D. Sacerdoti, M. Bolognesi, 1995, Hepatology.

Effects of amiloride on renal lithium handling in nonazotemic ascitic cirrhotic patients with avid sodium retention

P. Angeli, G. Ceolotto, L. Caregaro, 1992, Hepatology.

Hemodynamic evaluation of the addition of isosorbide‐5‐mononitrate to nadolol in cirrhotic patients with insufficient response to the β‐ blocker alone

P. Angeli, A. Gatta, D. Sacerdoti, 1997, Hepatology.

Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1986, British journal of clinical pharmacology.

Left ventricular diastolic function in liver cirrhosis.

A. Desideri, P. Angeli, A. Gatta, 1996, Scandinavian journal of gastroenterology.

The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.

P. Angeli, A. Gatta, M. Bolognesi, 1988, British journal of clinical pharmacology.

Mood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis C.

E. D. De Toni, P. Amodio, F. Del Piccolo, 2005, Journal of affective disorders.

Sublingual Captopril and Nifedipine in Immediate Treatment of Hypertensive Emergencies-Reply

P. Angeli, A. Gatta, 1992 .

Comparison of sublingual captopril and nifedipine in immediate treatment of hypertensive emergencies. A randomized, single-blind clinical trial.

P. Angeli, L. Caregaro, A. Gatta, 1991, Archives of internal medicine.

Detection of the early steps of cadmium nephropathy--comparison of light- and electron-microscopical patterns with the urinary enzymes excretion. An experimental study.

P. Angeli, P. Amodio, A. Gatta, 1989, Nephron.

Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC).

R. Cestari, G. Spinzi, P. Angeli, 2000, Gastroenterology.

5 Detection of minimal hepatic encephalopathy: EEG spectral analysis vs. cognitive evoked potentials

P. Amodio, A. Gatta, D. Mapelli, 2003 .

Portal hypertension: state of the art.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1999, Italian journal of gastroenterology and hepatology.

Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites

P. Angeli, G. Ceolotto, L. Caregaro, 1994, Hepatology.

175 TERLIPRESSIN GIVEN AS CONTINUOUS INTRAVENOUS INFUSION VERSUS TERLIPRESSIN GIVEN AS INTRAVENOUS BOLUSES IN THE TREATMENT OF TYPE 1 HEPATORENAL SYNDROME (HRS) IN PATIENTS WITH CIRRHOSIS

P. Angeli, A. Gatta, S. Fasolato, 2009 .

Surface expression of squamous cell carcinoma antigen (SCCA) can be increased by the preS1(21-47) sequence of hepatitis B virus.

P. Pontisso, G. Fassina, A. Gatta, 2004, The Journal of general virology.

Tubular handling of sodium and phosphate in non-ascitic liver cirrhosis.

P. Angeli, L. Caregaro, A. Gatta, 1987, Scandinavian journal of clinical and laboratory investigation.

F-50 Increased urinary level of neutrophil gelatinase–associated lipocalin (NGAL) in patients with cirrhosis and type 1 HRS

P. Angeli, A. Gatta, S. Fasolato, 2012 .

First evidence that albumin can directly improve cardiac contractility in cirrhotic rats

L. Franco, P. Angeli, G. Ceolotto, 2008 .

Terlipressin given as i.v. boluses vs terlipressin given as continuous intravenous infusion in patients with cirrhosis and type 1 hepatorenal sindrome(HRS): prelimnary results of a randomized controlled clinical study.

P. Angeli, A. Gatta, S. Fasolato, 2008 .

The liver: another organ involved in Muir Torre syndrome?

A. Gatta, C. Mescoli, M. Alaibac, 2012, Familial Cancer.

Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis

G. Marchesini, M. Zoli, D. Magalotti, 1996, Hepatology.

Characteristics of Minimal Hepatic Encephalopathy

M. Morgan, P. Amodio, A. Gatta, 2004, Metabolic Brain Disease.

Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement.

A. Gatta, C. Merkel, L. Arnaboldi, 1985, Clinical physiology.

Central Nervous System Alterations in Liver Cirrhosis: The Role of Portal-Systemic Shunt and Portal Hypoperfusion

P. Amodio, F. Del Piccolo, A. Gatta, 2003, Metabolic Brain Disease.

Central Nervous System Alterations in Liver Cirrhosis: The Role of Portal-Systemic Shunt and Portal Hypoperfusion

P. Amodio, F. Del Piccolo, A. Gatta, 2004, Metabolic Brain Disease.

Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis

P. Angeli, P. Amodio, A. Gatta, 2011, Hepatology.

Impairment of Response Inhibition Precedes Motor Alteration in the Early Stage of Liver Cirrhosis: A Behavioral and Electrophysiological Study

Antonino Vallesi, Sami Schiff, Daniela Mapelli, 2005, Metabolic Brain Disease.

Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients.

P. Angeli, P. Amodio, F. Del Piccolo, 2001, Journal of hepatology.

Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests

P. Angeli, L. Caregaro, P. Amodio, 1999, Hepatology.

Visual attention in cirrhotic patients: A study on covert visual attention orienting

L. Caregaro, P. Amodio, F. Del Piccolo, 1998, Hepatology.

Nutrition and survival in patients with liver cirrhosis.

L. Caregaro, P. Amodio, A. Gatta, 2001, Nutrition.

Malnutrition in alcoholic and virus-related cirrhosis.

P. Angeli, L. Caregaro, P. Amodio, 1996, The American journal of clinical nutrition.

Hepatotropic viruses: new insights in pathogenesis and treatment.

P. Pontisso, P. Lampertico, S. Quarta, 2008, Clinical and experimental rheumatology.

Severe acute hepatitis B in a treatment‐naïve patient with antiviral drug resistant mutations in the polymerase gene

P. Angeli, A. Gatta, S. Fasolato, 2013, Journal of medical virology.

Chronic hepatitis B in children after e antigen seroclearance: Final report of a 29‐year longitudinal study

A. Gatta, P. Cadrobbi, C. Crivellaro, 2006, Hepatology.

Comparison of thrice weekly vs daily human leucocyte interferon‐α therapy for chronic hepatitis C

A. Alberti, P. Pontisso, A. Gatta, 1999, Journal of viral hepatitis.

ß2-Microglobulin Concentration in Plasma and Production in Liver Cirrhosis

P. Amodio, A. Gatta, A. Ruol, 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Profiles of HCV core protein and viremia in chronic Hepatitis C: possible protective role of core antigen in liver damage

P. Pontisso, A. Gatta, N. Tono, 2005, Journal of medical virology.

Arterioportal fistulas in patients with liver cirrhosis: usefulness of color Doppler US for screening.

A. Gatta, D. Sacerdoti, M. Bolognesi, 2000, Radiology.

Neuropsychological–Neurophysiological Alterations and Brain Atrophy in Cirrhotic Patients

S. Luise, P. Amodio, F. Del Piccolo, 2003, Metabolic Brain Disease.

Prognostic significance of portal hemodynamics in patients with compensated cirrhosis.

G. Marchesini, M. Zoli, D. Magalotti, 1993, Journal of hepatology.

Spontaneous regression of hepatitis B virus-associated cirrhosis developed in childhood.

M. Rugge, A. Gatta, P. Cadrobbi, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.

A. Alberti, P. Pontisso, A. Gatta, 2001, Journal of hepatology.

Monitoring SCCA‐IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis

P. Pontisso, G. Fassina, S. Quarta, 2008, Journal of viral hepatitis.

SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis

P. Pontisso, Y. Hoshida, S. Quarta, 2014, British Journal of Cancer.

SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity

P. Pontisso, S. Quarta, A. Gatta, 2015, Scientific Reports.

Hepatic progenitor cells express SerpinB3

P. Pontisso, S. Quarta, D. Alvaro, 2014, BMC Cell Biology.

Plasma Carnitine Levels in Liver Cirrhosis: Relationship with Nutritional Status and Liver Damage

P. Angeli, P. Amodio, A. Gatta, 1990, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide

P. Angeli, L. Caregaro, P. Amodio, 1999, Hepatology.

Cognitive impairment and electroencephalographic alterations before and after liver transplantation: What is reversible?

P. Angeli, P. Amodio, A. Gatta, 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Hemodynamic changes of systemic, hepatic, and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis

P. Angeli, A. Gatta, M. Bolognesi, 1988, Digestive Diseases and Sciences.

Sleep‐wake abnormalities in patients with cirrhosis

D. Skene, P. Amodio, A. Gatta, 2014, Hepatology.

Tumour‐specific induction of immune complexes: DCP‐IgM in hepatocellular carcinoma

P. Pontisso, G. Fassina, A. Gatta, 2008, European journal of clinical investigation.

Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.

A. Gatta, F. Bianchi, L. Zancan, 2003, The Journal of pediatrics.

Parenchymal transforming growth factor beta‐1: Its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology

A. Alberti, P. Pontisso, A. Gatta, 2003, Journal of gastroenterology and hepatology.

CORRIGENDUM: SERPINB3 is associated with longer survival in transgenic mice

A. Avogaro, P. Pontisso, G. Ceolotto, 2014, Scientific Reports.

SERPINB3 induces epithelial–mesenchymal transition

P. Pontisso, G. Fassina, S. Quarta, 2009, The Journal of pathology.

Immune thrombocytopenic purpura and Kaposi’s sarcoma in a liver transplant recipient

P. Angeli, A. Gatta, S. Piano, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Role of spleen enlargement in cirrhosis with portal hypertension.

A. Gatta, D. Sacerdoti, M. Bolognesi, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Portal hypertension and portal hypertensive gastropathy in patients with liver cirrhosis: a haemodynamic study.

P. Angeli, A. Gatta, M. Bolognesi, 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment.

A. Gatta, D. Sacerdoti, M. Bolognesi, 1998, Journal of hepatology.

Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?

Angelo Gatta, M. Buendia, P. Pontisso, 2012, European journal of cancer.

The effect of aging on auditory components of event-related brain potentials

Sami Schiff, Piero Amodio, Pietro Valenti, 2008, Clinical Neurophysiology.

Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma

P. Pontisso, C. Belluco, D. Nitti, 2004, British Journal of Cancer.

Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis

P. Pontisso, G. Fassina, S. Meo, 2010, Clinical chemistry and laboratory medicine.

The effect of flumazenil on subclinical psychometric or neurophysiological alterations in cirrhotic patients: a double-blind placebo-controlled study.

P. Amodio, F. Del Piccolo, A. Gatta, 1997, Clinical physiology.

Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study

M. Ruzzoli, P. Angeli, P. Amodio, 2015, Liver international : official journal of the International Association for the Study of the Liver.

SERPINB3 modulates TGF-β expression in chronic liver disease

P. Pontisso, G. Fassina, S. Quarta, 2010, Laboratory Investigation.

Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.

P. Pontisso, G. Fassina, P. Angeli, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease

P. Pontisso, G. Fassina, S. Quarta, 2012, PloS one.

Covert hepatic encephalopathy: agreement and predictive validity of different indices.

P. Angeli, P. Amodio, A. Gatta, 2014, World journal of gastroenterology.

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis

A. Gatta, D. Sacerdoti, M. Bolognesi, 2000, Hepatology.

Change in portal flow after liver transplantation: Effect on hepatic arterial resistance indices and role of spleen size

Angelo Gatta, Paolo Angeli, P. Angeli, 2002, Hepatology.

Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial

Ezio Fornasiere, Manuela Merli, Mauro Bernardi, 2015, Hepatology.

Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features

P. Angeli, A. Gatta, S. Fasolato, 2007, Hepatology.

The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated cirrhosis: Results of a randomized controlled clinical trial

P. Angeli, A. Gatta, M. Senzolo, 2015 .

Renal vasoconstriction in cirrhosis

P. Angeli, A. Gatta, A. Colli, 1994, Hepatology.

Pharmacokinetics of iloprost in patients with hepatic dysfunction.

P. Angeli, A. Gatta, W. Krause, 1990, International journal of clinical pharmacology, therapy, and toxicology.

How to improve care in outpatients with cirrhosis and ascites: a new model of care coordination by consultant hepatologists.

A. Frigo, P. Angeli, A. Gatta, 2013, Journal of hepatology.

The EEG assessment of low-grade hepatic encephalopathy: Comparison of an artificial neural network-expert system (ANNES) based evaluation with visual EEG readings and EEG spectral analysis

J. Guérit, P. Amodio, A. Gatta, 2006, Clinical Neurophysiology.

Improving the inhibitory control task to detect minimal hepatic encephalopathy.

P. Bisiacchi, P. Angeli, G. Cona, 2010, Gastroenterology.

Nutritional and prognostic significance of insulin-like growth factor 1 in patients with liver cirrhosis.

P. Angeli, M. Plebani, L. Caregaro, 1997, Nutrition.

Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.

Daniela Mapelli, Piero Amodio, Marco Penzo, 2008, Journal of hepatology.

Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.

Angelo Gatta, J. Mcgiff, A. Gatta, 2003, Prostaglandins & other lipid mediators.

Are prealbumin plasma levels linked to amino acid supply from peripheral tissues in liver cirrhosis?

P. Amodio, A. Gatta, M. Bolognesi, 1992, Amino Acids.

Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.

P. Angeli, L. Caregaro, A. Gatta, 1989, Journal of hepatology.

Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension.

A. Gatta, D. Sacerdoti, C. Merkel, 1984, American heart journal.

The course of galactose elimination capacity in patients with alcoholic cirrhosis: Possible use as a surrogate marker for death

G. Marchesini, M. Zoli, A. Gatta, 1996, Hepatology.

Session 8 ‒ Complications in the Medical Treatment of Portal Hypertension

G. Stiegmann, J. Rodés, M. Merli, 2008 .

Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking

D. Aprile, P. Angeli, P. Amodio, 2013, Metabolic Brain Disease.

Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis

P. Achermann, P. Amodio, A. Gatta, 2012, Hepatology.

Attention Dysfunction in Cirrhotic Patients: An Inquiry on the Role of Executive Control, Attention Orienting and Focusing

C. Umilta, P. Amodio, A. Gatta, 2005, Metabolic Brain Disease.

Natural history of cirrhotic patients with small esophageal varices: a prospective study

M. Zoli, D. Magalotti, A. Gatta, 2000, American Journal of Gastroenterology.

Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy.

O. Riggio, P. Amodio, A. Gatta, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites.

A. Frigo, P. Angeli, A. Gatta, 2013, Journal of hepatology.

Study on the Sternberg Paradigm in Cirrhotic Patients Without Overt Hepatic Encephalopathy

L. Caregaro, P. Amodio, F. Del Piccolo, 1998, Metabolic Brain Disease.

Acute liver rejection: accuracy and predictive values of doppler US measurements--initial experience.

M. Rugge, P. Angeli, A. Gatta, 2005, Radiology.

Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index

M. Zoli, L. Bolondi, P. Angeli, 2000, American Journal of Gastroenterology.

Long‐term effect of nadolol or nadolol plus isosorbide‐5‐mononitrate on renal function and ascites formation in patients with cirrhosis

P. Angeli, P. Amodio, A. Gatta, 1995 .

Sleep and Circadian Rhythms in Hospitalized Patients with Decompensated Cirrhosis: Effect of Light Therapy

D. Skene, B. Middleton, P. Amodio, 2015, Neurochemical Research.

Reference ranges and methodological aspects in the urinary measuring of lysozyme, malate-dehydrogenase, gamma-glutamyltransferase and alpha-glucosidase.

P. Amodio, A. Gatta, R. Malatesta, 1985, Enzyme.

Mood, cognition and EEG changes during interferon α (alpha-IFN) treatment for chronic hepatitis C

E. D. De Toni, P. Amodio, A. Gatta, 2005 .

Cognitive effects of long-term interferon treatment for chronic viral hepatitis

C. Umilta, A. Alberti, P. Amodio, 2003 .

Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis

G. Marchesini, M. Zoli, P. Angeli, 1991, Digestive Diseases and Sciences.

Long‐term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis

P. Amodio, A. Gatta, C. Mazzaro, 2000, Hepatology.

Development and validation of a prognostic index predicting death after upper gastrointestinal bleeding in patients with liver cirrhosis: a multicenter study.

P. Amodio, A. Gatta, M. Bolognesi, 1994, The American journal of gastroenterology.

Variability of Trail Making Test, Symbol Digit Test and Line Trait Test in normal people. A normative study taking into account age-dependent decline and sociobiological variables

Daniela Mapelli, Carlo Umiltà, Sara Montagnese, 2002, Aging clinical and experimental research.

Changes in porto-hepatic hemodynamics during acute rejection (AR) in patients with liver transplant (OLT)

A. Gatta, D. Sacerdoti, M. Bolognesi, 2002 .

Long-term follow-up study of adult patients with non-cirrhotic obstruction of the portal system: comparison with cirrhotic patients.

P. Amodio, A. Gatta, D. Sacerdoti, 1992, Journal of hepatology.

The Influence of Environmental Factors on Sleep Quality in Hospitalized Medical Patients

Sara Montagnese, Piero Amodio, Matteo Turco, 2014, Front. Neurol..

127 Beta-blockers in the prevention of aggravation of esophageal varices in patients with cirrhosis and small varices: a placebo-controlled clinical trial

P. Angeli, A. Gatta, M. Bolognesi, 2003 .

The cirrhotic patient with no varices and with small varices

A. Gatta, M. Bolognesi, C. Merkel, 2004 .

Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.

M. Zoli, P. Amodio, A. Gatta, 2010, Journal of Hepatology.

Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices.

P. Angeli, A. Gatta, D. Sacerdoti, 1992, Gastroenterology.

Electroencephalographic analysis for the assessment of hepatic encephalopathy: Comparison of non-parametric and parametric spectral estimation techniques

S. Schiff, G. Toffolo, P. Amodio, 2009, Neurophysiologie Clinique/Clinical Neurophysiology.

Visual attention orienting in liver cirrhosis without overt hepatic encephalopathy

G. Sartori, P. Amodio, A. Gatta, 1995, Metabolic Brain Disease.

Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis.

A. Gatta, D. Sacerdoti, C. Merkel, 1991, Journal of hepatology.

Distal renal tubular acidosis in hepatic cirrhosis: clinical and pathogenetic study.

L. Caregaro, A. Gatta, C. Merkel, 1981, Clinical nephrology.

OC-4 Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumor?

M. Buendia, P. Pontisso, S. Quarta, 2011 .

Renal Haemodynamics in Essential Hypertension Assessed by 133-Xenon Washout and Selective Renal Angiography

A. Gatta, A. Pessina, D. Sacerdoti, 1982, Angiology.

Renal effects of aminophylline in hepatic cirrhosis

A. Gatta, C. Merkel, L. Milani, 2004, European Journal of Clinical Pharmacology.

Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD

P. Pontisso, G. Fassina, S. Quarta, 2011, Experimental biology and medicine.

Noninvasive grading of the severity of portal hypertension in cirrhotic patients by echo-color-Doppler.

A. Gatta, D. Sacerdoti, M. Bolognesi, 2001, Ultrasound in medicine & biology.

P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough.

S. Schiff, P. Angeli, P. Amodio, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG

P. Amodio, A. Gatta, F. Piccolo, 1996, Metabolic Brain Disease.

Peripheral neurotoxicity of pegylated interferon alpha: a prospective study in patients with HCV.

M. Ermani, L. Battistin, C. Briani, 2006, Neurology.

Analysis of EEG tracings in frequency and time domain in hepatic encephalopathy

Piero Amodio, S. Montagnese, D. Pascoli, 2006, Comput. Methods Programs Biomed..

O093 : The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis : Results of a randomized controlled clinical trial

P. Angeli, A. Gatta, M. Senzolo, 2015 .

Prognostic Benefit of the Addition of a Quantitative Index of Hepatic Encephalopathy to the MELD score: the MELD‐EEG

Sami Schiff, Sara Montagnese, Piero Amodio, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Hepatic encephalopathy: you should only comment on what you have actually measured

M. Morgan, O. Riggio, P. Amodio, 2010, Journal of Gastroenterology.

Neurophysiological Investigation of Hepatic Encephalopathy

P. Amodio, A. Gatta, 2005, Metabolic Brain Disease.

Impaired renal water excretion in liver cirrhosis. The role of reduced distal delivery of sodium.

P. Angeli, L. Caregaro, A. Gatta, 1988, Scandinavian journal of gastroenterology.

Electroencephalography in patients with cirrhosis.

G. Toffolo, F. Piccione, P. Kaplan, 2011, Gastroenterology.

Can we predict the first variceal bleeding in the individual patient with cirrhosis and esophageal varices?

A. Gatta, C. Merkel, 1991, Journal of hepatology.

Aminopyrine breath test in the prognostic evaluation of patients with cirrhosis.

P. Angeli, A. Gatta, M. Bolognesi, 1992, Gut.

Role of the Heme Oxygenases in Abnormalities of the Mesenteric Circulation in Cirrhotic Rats

N. Abraham, J. Mcgiff, A. Gatta, 2004, Journal of Pharmacology and Experimental Therapeutics.

Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis.

P. Angeli, P. Amodio, A. Gatta, 1990, British journal of clinical pharmacology.

181 CLINICAL SIGNIFICANCE OF THE WORSENING IN PORTAL HYPERTENSION DURING LONG-TERM DRUG TREATMENT IN CIRRHOTIC PATIENTS WHO WERE GOOD-RESPONDERS AT SHORT TERM

P. Amodio, A. Gatta, M. Bolognesi, 2009 .

Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation

M. Bolognesi, A. Gatta, D. Sacerdoti, 2005, Alimentary pharmacology & therapeutics.

Occult liver disease burden: Analysis from a large general practitioners’ database

P. Pontisso, P. Angeli, A. Gatta, 2017, United European gastroenterology journal.

Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis

V. Arroyo, P. Angeli, J. Rodés, 1995, Hepatology.

FAST TRACK Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma

P. Pontisso, G. Fassina, S. Quarta, 2014 .

Vitamin E does not reduce ribavirin associated anaemia during combination therapy for hepatitis C

A. Alberti, A. Gatta, A. Ferrari, 2002 .

Alcohol- and substance-dependent subjects: the correlated factors in qualifying for liver transplantation.

A. Gatta, D. D’amico, A. Vitale, 2007, Transplantation Proceedings.

Monoclonal gammopathy after liver transplantation: a risk factor for long‐term medical complications other than malignancies

A. Frigo, P. Angeli, M. Plebani, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Splanchnic impedance indices in portal hypertension

A. Favero, A. Gatta, D. Sacerdoti, 1998 .

The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C

A. Alberti, P. Pontisso, A. Gatta, 2000 .

Covert hepatic encephalopathy: does the mini-mental state examination help?

P. Angeli, P. Amodio, A. Gatta, 2014, Journal of clinical and experimental hepatology.

Long term e V ect of alpha interferon in children with chronic hepatitis B

A. Gatta, L. Zancan, P. Jara, 2000 .

Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group.

A. Alberti, A. Gatta, C. Merkel, 1999, Hepato-gastroenterology.

Erratum to: Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry

A. Farcomeni, G. Corazza, F. Perticone, 2016, Internal and Emergency Medicine.

A patients’ and caregivers’ perspective on hepatic encephalopathy

S. Schiff, P. Angeli, P. Amodio, 2012, Metabolic Brain Disease.

Statistical methods for predicting variceal hemorrhage.

A. Gatta, C. Merkel, 1992, Gastroenterology.

Updating prognosis of cirrhosis by Cox's regression model using Child-Pugh score and aminopyrine breath test as time-dependent covariates.

A. Morabito, P. Angeli, A. Gatta, 1998, Italian journal of gastroenterology and hepatology.

Hepatitis C virus reinfection in liver transplant patients: Evaluation of liver damage progression with echo‐color doppler

M. Rugge, A. Gatta, D. Sacerdoti, 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Evaluation of splanchnic angiography as a prognostic index of survival in patients with cirrhosis.

A. Gatta, C. Merkel, P. Mormino, 1991, Scandinavian journal of gastroenterology.

Are urinary enzymes useful markers of kidney damage in obstructive jaundice? An experimental study on Sprague-Dawley rats.

P. Amodio, A. Gatta, P. Rigotti, 1985, Nephron.

Rifaximin reduces EEG relative beta power in patients with minimal hepatic encephalopathy: preliminary findings

P. Amodio, A. Gatta, D. Mapelli, 2003 .

Evaluation of visual focus in cirrhotic patients

C. Umilta, P. Amodio, A. Gatta, 2003 .

The EEG Signal In Hepatic Encephalopathy: from a Time-Domain Statistical Analysis towards Fractional Brownian Processes

P. Amodio, A. Gatta, D. Pascoli, 2002 .

Treatment of patients with cirrhosis and refractory ascites using LeVeen shunt with titanium tip: Comparison with therapeutic paracentesis

V. Arroyo, P. Angeli, J. Rodés, 1995, Hepatology.